Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Payables (2018 - 2025)

Health Catalyst's Payables history spans 8 years, with the latest figure at $9.4 million for Q4 2025.

  • For Q4 2025, Payables fell 18.11% year-over-year to $9.4 million; the TTM value through Dec 2025 reached $9.4 million, down 18.11%, while the annual FY2025 figure was $9.4 million, 18.11% down from the prior year.
  • Payables reached $9.4 million in Q4 2025 per HCAT's latest filing, up from $4.9 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $14.3 million in Q3 2024 to a low of $4.4 million in Q4 2022.
  • Average Payables over 5 years is $7.3 million, with a median of $6.5 million recorded in 2023.
  • Peak YoY movement for Payables: soared 125.67% in 2024, then tumbled 65.38% in 2025.
  • A 5-year view of Payables shows it stood at $4.7 million in 2021, then decreased by 5.73% to $4.4 million in 2022, then soared by 50.11% to $6.6 million in 2023, then soared by 72.16% to $11.4 million in 2024, then fell by 18.11% to $9.4 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Payables are $9.4 million (Q4 2025), $4.9 million (Q3 2025), and $8.9 million (Q2 2025).